skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 3,610  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
Material Type:
Article
Add to My Research

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

The Lancet infectious diseases, 2016-07, Vol.16 (7), p.828-837 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jul 01, 2016 ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(16)00071-2 ;PMID: 26969258 ;CODEN: LANCAO

Full text available

2
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial
Material Type:
Article
Add to My Research

Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial

The Lancet (British edition), 2016-12, Vol.388 (10063), p.2997-3005 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 17, 2016 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)32389-3 ;PMID: 27908454 ;CODEN: LANCAO

Full text available

3
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
Material Type:
Article
Add to My Research

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

The Lancet (British edition), 2016-02, Vol.387 (10020), p.760-769 [Peer Reviewed Journal]

Elsevier Ltd ;2016 Elsevier Ltd ;Copyright © 2016 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Feb 20, 2016 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(15)01159-9 ;PMID: 26684607 ;CODEN: LANCAO

Full text available

4
Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy
Material Type:
Article
Add to My Research

Comparison of PAM50 Risk of Recurrence Score With Oncotype DX and IHC4 for Predicting Risk of Distant Recurrence After Endocrine Therapy

Journal of clinical oncology, 2013-08, Vol.31 (22), p.2783-2790 [Peer Reviewed Journal]

2014 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2012.46.1558 ;PMID: 23816962

Full text available

5
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes
Material Type:
Article
Add to My Research

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

The New England journal of medicine, 2015-07, Vol.373 (3), p.232-242 [Peer Reviewed Journal]

Copyright © 2015 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1501352 ;PMID: 26052984

Full text available

6
Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial
Material Type:
Article
Add to My Research

Benznidazole and Posaconazole in Eliminating Parasites in Asymptomatic T. Cruzi Carriers: The STOP-CHAGAS Trial

Journal of the American College of Cardiology, 2017-02, Vol.69 (8), p.939-947 [Peer Reviewed Journal]

Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Feb 28, 2017 ;ISSN: 0735-1097 ;EISSN: 1558-3597 ;DOI: 10.1016/j.jacc.2016.12.023 ;PMID: 28231946

Full text available

7
COVID‐19 Associated Pulmonary Aspergillosis
Material Type:
Article
Add to My Research

COVID‐19 Associated Pulmonary Aspergillosis

Mycoses, 2020-06 [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1111/myc.13096

Digital Resources/Online E-Resources

8
Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
Material Type:
Article
Add to My Research

Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer

Nature (London), 2014-06, Vol.510 (7504), p.278-282 [Peer Reviewed Journal]

COPYRIGHT 2014 Nature Publishing Group ;COPYRIGHT 2014 Nature Publishing Group ;Copyright Nature Publishing Group Jun 12, 2014 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature13229 ;PMID: 24759320 ;CODEN: NATUAS

Full text available

9
Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence
Material Type:
Article
Add to My Research

Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence

Journal of clinical oncology, 2016-07, Vol.34 (21), p.2452-2459 [Peer Reviewed Journal]

2016 by American Society of Clinical Oncology. ;2016 by American Society of Clinical Oncology 2016 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2015.63.8619 ;PMID: 27217455

Full text available

10
Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
Material Type:
Article
Add to My Research

Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)

Journal of clinical oncology, 2017-04, Vol.35 (10), p.1061-1069 [Peer Reviewed Journal]

2017 by American Society of Clinical Oncology 2017 American Society of Clinical Oncology ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/jco.2016.69.4406 ;PMID: 28045625

Full text available

11
Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice
Material Type:
Article
Add to My Research

Catalytic site inhibition of insulin-degrading enzyme by a small molecule induces glucose intolerance in mice

Nature communications, 2015-09, Vol.6 (1), p.8250-8250, Article 8250 [Peer Reviewed Journal]

Copyright Nature Publishing Group Sep 2015 ;Attribution ;Copyright © 2015, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/ncomms9250 ;PMID: 26394692

Full text available

12
Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement
Material Type:
Article
Add to My Research

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement

Annals of the rheumatic diseases, 2021-01, Vol.80 (1), p.71-87 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2020-218398 ;PMID: 33158881

Full text available

13
Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial
Material Type:
Article
Add to My Research

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial

The lancet oncology, 2010-12, Vol.11 (12), p.1135-1141 [Peer Reviewed Journal]

Elsevier Ltd ;2010 Elsevier Ltd ;Copyright © 2010 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 2010 ;ISSN: 1470-2045 ;EISSN: 1474-5488 ;DOI: 10.1016/S1470-2045(10)70257-6 ;PMID: 21087898 ;CODEN: LANCAO

Full text available

14
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial
Material Type:
Article
Add to My Research

Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial

Lancet neurology, 2014-05, Vol.13 (5), p.461-471 [Peer Reviewed Journal]

Elsevier Ltd ;2014 Elsevier Ltd ;Copyright © 2014 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited May 2014 ;ISSN: 1474-4422 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(14)70053-5 ;PMID: 24680372 ;CODEN: LANCAO

Full text available

15
Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia
Material Type:
Article
Add to My Research

Safety and efficacy of selinexor in relapsed or refractory multiple myeloma and Waldenstrom macroglobulinemia

Blood, 2018-02, Vol.131 (8), p.855-863 [Peer Reviewed Journal]

2018 American Society of Hematology ;2018 by The American Society of Hematology. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2017-08-797886 ;PMID: 29203585

Full text available

16
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial
Material Type:
Article
Add to My Research

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial

The Lancet (British edition), 2014-03, Vol.383 (9922), p.1041-1048 [Peer Reviewed Journal]

Cuzick et al. Open Access article distributed under the terms of CC BY ;2015 INIST-CNRS ;Copyright © 2014 Cuzick et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Mar 22, 2014 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(13)62292-8 ;PMID: 24333009 ;CODEN: LANCAO

Full text available

17
Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions
Material Type:
Article
Add to My Research

Breakthrough Invasive Mold Infections in the Hematology Patient: Current Concepts and Future Directions

Clinical infectious diseases, 2018-10, Vol.67 (10), p.1621-1630 [Peer Reviewed Journal]

The Author(s) 2018. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2018 ;ISSN: 1058-4838 ;EISSN: 1537-6591 ;DOI: 10.1093/cid/ciy473 ;PMID: 29860307

Full text available

18
Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial
Material Type:
Article
Add to My Research

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial

The Lancet (British edition), 2018-12, Vol.392 (10162), p.2378-2387 [Peer Reviewed Journal]

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Dec 1, 2018 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)32463-2 ;PMID: 30360970

Full text available

19
The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance
Material Type:
Article
Add to My Research

The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance

Human reproduction update, 2016-11, Vol.22 (6), p.687-708 [Peer Reviewed Journal]

The Author 2016. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. ;ISSN: 1355-4786 ;ISSN: 1460-2369 ;EISSN: 1460-2369 ;DOI: 10.1093/humupd/dmw025 ;PMID: 27511809

Full text available

20
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients
Material Type:
Article
Add to My Research

Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients

Cancer cell, 2016-04, Vol.29 (4), p.587-601 [Peer Reviewed Journal]

2016 Elsevier Inc. ;Copyright © 2016 Elsevier Inc. All rights reserved. ;ISSN: 1535-6108 ;ISSN: 1878-3686 ;EISSN: 1878-3686 ;DOI: 10.1016/j.ccell.2016.03.005 ;PMID: 27070705

Full text available

Results 1 - 20 of 3,610  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (3,409)

Refine My Results

Creation Date 

From To
  1. Before 1981  (26)
  2. 1981 To 1991  (107)
  3. 1992 To 2001  (347)
  4. 2002 To 2012  (1,921)
  5. After 2012  (1,209)
  6. More options open sub menu

Language 

  1. English  (3,514)
  2. Japanese  (481)
  3. German  (59)
  4. Spanish  (41)
  5. French  (24)
  6. Portuguese  (18)
  7. Italian  (7)
  8. Russian  (3)
  9. Turkish  (3)
  10. Dutch  (3)
  11. Swedish  (2)
  12. Chinese  (2)
  13. Hungarian  (1)
  14. Norwegian  (1)
  15. More options open sub menu

Searching Remote Databases, Please Wait